Esperion Therapeutics | Vendas

Preço das Ações
3.49
Mudança Diária
0.10 2.80%
Mensal
-1.83%
Anual
85.37%
Q1 Previsão
2.70




Vendas Alterar Data
AbbVie USD 16.62B 840M 2025-12
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amarin USD 49.67M 23.07M 2025-09
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Cipla INR 75.18B 710M 2025-12
CSL USD 3.54B 4.68B 2025-06
Cytokinetics USD 1.93M 64.83M 2025-09
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Geron USD 47.2M 1.8M 2025-09
Grifols EUR 2.18B 37.55M 2025-09
Halozyme Therapeutics USD 354M 148M 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Merck USD 16.4B 880M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.02B 878M 2025-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
United Therapeutics USD 799.5M 900K 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Esperion Therapeutics Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.